Health News

Health News

RSS Feed

DATROWAY® Demonstrated an Unprecedented Median Overall Survival Improvement of Five Months Vs Chemotherapy as First-line Treatment for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02

2:30 AM on Sunday, October 19

KEYTRUDA® (pembrolizumab) Plus Chemotherapy With or Without Bevacizumab Reduced Risk of Disease Progression or Death Versus Chemotherapy With or Without Bevacizumab in Certain Patients With Platinum-Resistant Recurrent Ovarian Cancer

10:35 AM on Saturday, October 18

ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease recurrence or death by 53% vs. T-DM1 in patients with high-risk HER2-positive early breast cancer following neoadjuvant therapy in DESTINY-Breast05 Phase III trial

10:35 AM on Saturday, October 18

KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Event-Free Survival Events by 60% and Risk of Death by 50% for Certain Patients with Muscle-Invasive Bladder Cancer When Given Before and After Surgery

10:30 AM on Saturday, October 18

ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial

10:30 AM on Saturday, October 18

ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in DESTINY-Breast05 Phase 3 Trial

10:30 AM on Saturday, October 18

Nurse Rod Salaysay plays guitar for patient Richard Hoang in the recovery unit of UC San Diego Health in San Diego, Calif., on Sept. 30, 2025. (AP Photo/Javier Arciga)

Music could help ease pain from surgery or illness. Scientists are listening

9:04 AM on Saturday, October 18

Hospitals and doctors' offices are inviting singers and musicians to help patients manage their pain, as music's ability to reduce pain is gaining attention

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 2025

7:00 AM on Saturday, October 18

KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Based Regimen

6:00 AM on Saturday, October 18

Third-floor balcony in Cincinnati collapses, sending 10 people to the hospital

12:12 AM on Saturday, October 18

Officials say a balcony on the third floor of a building near the University of Cincinnati has collapsed, sending 10 people to the hospital

TEZSPIRE approved in the US for chronic rhinosinusitis with nasal polyps

4:17 PM on Friday, October 17

1 2 3 4 5 ... Last

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • Eric Metaxas Show
    2:00AM - 4:00AM
     
    The Eric Metaxas Show offers compelling perspective on American culture,   >>
     
  • Best of Mike Gallagher
    4:00AM - 6:00AM
     
    Known as "The Happy Conservative Warrior," Mike Gallagher is one of the most consistently popular hosts in America.
     
  • Radio Health Journal
    6:00AM - 6:30AM
     
    Radio Health Journal offers the latest scoop on what’s trending in health,   >>
     
  • Viewpoints Radio
    6:30AM - 7:00AM
     
    Sit down with Viewpoints each week as we report on social issues, the   >>
     
  • Wyatt Matters
    7:00AM - 8:00AM
     
    Wyatt Matters takes a lighthearted approach to things that deeply matter by   >>
     

See the Full Program Guide